Characteristics of 53 patients with RA whose disease flared after discontinuation of second line treatment while being in remission
| Characteristic | |
| Age (years)* | 59.9 (11.4) |
| Female (%) | 60 |
| Duration of RA (years)* | 10.6 (9) |
| ELISA IgM-RF positive (%) | 77 |
| Erosive changes on x ray (%) | 75 |
| Weeks between entry in the placebo controlled study and flare† | 27 (3 to 52) |
| Number of patients with severe flare | 24 |
Data shown as mean (SD)* and median (range)†.